Serge Marchand

Oct 20, 2023 | mdpi.com | Stéphane Potvin |Serge Marchand |Alexander McIntyre |Gaël Villanueva-Charbonneau

1. IntroductionThere has been an ongoing interest in identifying biomarkers related to mood and pain disorders. Despite high comorbidity rates, especially in the case of major depressive disorder (MDD) and functional pain syndromes, such as fibromyalgia (FM), few studies have focused on their frequent co-occurrence. Fibromyalgia (FM) affects between 0.2% and 6.6% of the population worldwide [1].